Latest Protein-bound paclitaxel Stories
-- ABRAXANE plus gemcitabine approved by the TGA for the first-line treatment of metastatic pancreatic cancer MELBOURNE, Australia, March 18, 2014 /PRNewswire/ -- Australian biopharmaceutical
SAN DIEGO, March 6, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN DIEGO, Feb. 11, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN DIEGO, Feb. 10, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
MELBOURNE, Australia, Jan.
By all measures, the addition of nab-paclitaxel for the treatment of patients with advanced pancreatic cancer was superior to the survival for patients who received only gemcitabine.
Reportbuyer.com just published a new market research report:
- A political dynamiter.